Monday, Oct 24th

Last update05:20:13 AM GMT

You are here News Health FDA staff note deaths in Pfizer bone drug study

FDA staff note deaths in Pfizer bone drug study

E-mail Print PDF
A higher percentage of patients treated with an experimental Pfizer Inc drug for osteoporosis died during a clinical trial compared with a placebo, U.S. drug reviewers said in an analysis released on Thursday.

The higher proportion of deaths through five years was statistically significant only for the lowest dose of the drug called Fablyn, said Food and Drug Administration reviewers. More patients given Fablyn, which was co-developed with Ligand Pharmaceuticals Inc, also developed blood clots.


Most Recent Related Stories...

Youth football players show brain changes after just one season

Football brain injuriesWhen it comes to head impact in youth football, it is not just concussion that affects...

St. Jude warns of heart-device battery issue linked to two deaths

St. Jude'sSt. Jude Medical Inc warned on Tuesday that some of its implanted heart devices were at...

Americans overwhelmingly support abortion rights

Americans support abortion rightsPolitical candidates, consultants and the media generally misunderstand the politics of abortion rights. They tend to...

France to open first safe-injection room for drug addicts

safe heroin injection room opened in FranceFrance will open its first safe-injection room for drug addicts despite years of efforts by conservatives...
America's # 1 Enemy
Tee Shirt
& Help Support!
TVNL Tee Shirt
Conserve our Planet
& Help Support!
Get your 9/11 & Media
Deception Dollars
& Help Support!
The Loaded Deck
The First & the Best!
The Media & Bush Admin Exposed!